Hi-Tech Pharmacal Co., Inc. Sustainability Profile
Hi-Tech Pharmacal Co., Inc., commonly referred to as Hi-Tech, is a prominent player in the pharmaceutical industry, headquartered in the United States. Founded in 1983, the company has established itself as a leader in the development and manufacturing of generic and specialty pharmaceuticals, particularly in the fields of liquid and semi-solid dosage forms. With major operational regions across the US, Hi-Tech Pharmacal is renowned for its commitment to quality and innovation. The company offers a diverse range of products, including prescription medications and over-the-counter solutions, distinguished by their unique formulations and adherence to stringent regulatory standards. Hi-Tech's market position is bolstered by its notable achievements in product development and a robust portfolio that addresses various therapeutic areas, making it a trusted name in healthcare.
DitchCarbon Score
How does Hi-Tech Pharmacal Co., Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hi-Tech Pharmacal Co., Inc.'s score of 23 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Hi-Tech Pharmacal Co., Inc.'s reported carbon emissions
Hi-Tech Pharmacal Co., Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a current subsidiary, Hi-Tech Pharmacal's climate commitments and emissions data may be influenced by its corporate family relationships; however, no specific initiatives or targets have been cascaded from a parent organisation. The lack of reported emissions and reduction initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. In the broader context of the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and are setting ambitious targets to reduce their carbon footprints. It remains to be seen how Hi-Tech Pharmacal will align with these industry trends in the future.
How Carbon Intensive is Hi-Tech Pharmacal Co., Inc.'s Industry?
How Carbon Intensive is Hi-Tech Pharmacal Co., Inc.'s Location?
Hi-Tech Pharmacal Co., Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Hi-Tech Pharmacal Co., Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
